Customized microperimetry helped researchers track geographic atrophy in patients undergoing CTx001 gene therapy, according ...

Many neurological diseases damage specific parts of the brain, even though the harmful protein involved is present throughout the brain.

A new study combines tau PET with network mapping to prove remote circuit disruption drives cognitive symptoms in PSP.

For decades, researchers studying myotonic dystrophy type 1 (DM1) have focused on the disease's underlying genetic cause: a ...

Early detection and treatment of congenital cerebral ventriculomegaly (CCV)—when a fetus's fluid-filled brain ventricles ...

Patients may not know that these treatments are experimental or about the risks they may pose. The latest in AJC's ...

Medical conditions - full list. Notifiable conditions are medical issues that could potentially compromise your ability to drive safely. These include sleep apnoea, fainting (sync ...

Alzheon, Inc., a clinical-stage biopharmaceutical company developing investigational therapies and diagnostic assays for Alzheimer's disease (AD) and other neurodegenerative disorders, today announced ...

Scientists studying brain aging have turned to an unexpected research partner living right in our homes. What they discovered about the aging feline brain may reshape how we understand and treat ...

Geographic atrophy can emerge during stable anti-VEGF regimens for bilateral wet AMD, requiring deliberate surveillance and patient counseling rather than “treat-and-forget” follow-up. Coordinating ...